Report: Global biosimilars market could reach $2.5B this year

05/7/2013 | Drug Store News

The global biosimilars market is forecast to expand to $2.5 billion this year, a growth of more than 20% from 2012, according to a report from U.K.-based firm Visiongain. The market could see rapid expansion through 2023 as biosimilar drugs enter the U.S. and European markets. Biosimilar versions of monoclonal antibodies and insulins will record the fastest growth, according to the report, which point to the potential product launches in Europe and the U.S. next year.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN